CN109337845B - Acinetobacter Y-3L-asparaginase gene and expression and application thereof - Google Patents
Acinetobacter Y-3L-asparaginase gene and expression and application thereof Download PDFInfo
- Publication number
- CN109337845B CN109337845B CN201811384145.0A CN201811384145A CN109337845B CN 109337845 B CN109337845 B CN 109337845B CN 201811384145 A CN201811384145 A CN 201811384145A CN 109337845 B CN109337845 B CN 109337845B
- Authority
- CN
- China
- Prior art keywords
- asparaginase
- acinetobacter
- gene
- asaase
- pcr amplification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000589291 Acinetobacter Species 0.000 title claims abstract description 20
- 108090000623 proteins and genes Proteins 0.000 title abstract description 22
- 230000014509 gene expression Effects 0.000 title abstract description 13
- 229960003272 asparaginase Drugs 0.000 title abstract description 12
- 108010024976 Asparaginase Proteins 0.000 claims abstract description 60
- 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 claims abstract description 42
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000013305 food Nutrition 0.000 claims abstract description 18
- 239000002773 nucleotide Substances 0.000 claims abstract description 3
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 3
- 239000002689 soil Substances 0.000 claims abstract description 3
- 238000012408 PCR amplification Methods 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 239000013604 expression vector Substances 0.000 claims description 6
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 238000011144 upstream manufacturing Methods 0.000 claims description 4
- 244000063299 Bacillus subtilis Species 0.000 claims description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 238000000137 annealing Methods 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000012257 pre-denaturation Methods 0.000 claims description 3
- 230000009465 prokaryotic expression Effects 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- SPJOZZSIXXJYBT-UHFFFAOYSA-N Fenson Chemical compound C1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 SPJOZZSIXXJYBT-UHFFFAOYSA-N 0.000 claims description 2
- 238000009629 microbiological culture Methods 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 230000005764 inhibitory process Effects 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 229920002472 Starch Polymers 0.000 abstract description 4
- 235000019698 starch Nutrition 0.000 abstract description 4
- 239000008107 starch Substances 0.000 abstract description 4
- 230000000711 cancerogenic effect Effects 0.000 abstract description 3
- 231100000357 carcinogen Toxicity 0.000 abstract description 2
- 239000003183 carcinogenic agent Substances 0.000 abstract description 2
- 230000003197 catalytic effect Effects 0.000 abstract 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 10
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 235000013606 potato chips Nutrition 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229960001230 asparagine Drugs 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 241001052560 Thallis Species 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000010353 genetic engineering Methods 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000015790 Asparaginase Human genes 0.000 description 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 3
- 240000000220 Panda oleosa Species 0.000 description 3
- 235000016496 Panda oleosa Nutrition 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 3
- 235000009582 asparagine Nutrition 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 229960005261 aspartic acid Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000271152 Acinetobacter soli Species 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 101710180958 Putative aminoacrylate hydrolase RutD Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- -1 salt ions Chemical class 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/25—Removal of unwanted matter, e.g. deodorisation or detoxification using enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
- C12N9/82—Asparaginase (3.5.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
- C12Y305/01001—Asparaginase (3.5.1.1)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention relates to an acinetobacter Y-3L-asparaginase gene and expression and application thereof. The L-asparaginase gene disclosed by the invention is derived from a strain of acinetobacter which is screened from soilAcinetobacter soli) Y-3 (seed deposit number: CGMCC NO. 14831), the nucleotide sequence of which is shown as SEQ ID NO. 1. The L-asparaginase has good catalytic activity, effectively inhibits the generation of acrylamide in fried foods, can radically control the generation of potential carcinogen acrylamide in the high-temperature processing of starch-containing foods, and has wide application prospect in the field of food processing.
Description
Technical Field
The invention relates to an acinetobacter Y-3L-asparaginase gene and expression and application thereof, belonging to the technical field of biology.
Background
L-asparaginase (EC3.5.1.1), which is a threonine amino hydrolase, specifically catalyzes the formation of L-aspartic acid and ammonia from L-asparagine. The L-asparaginase can hydrolyze asparagine to prevent Maillard reaction of asparagine and reducing sugar to generate acrylamide, so that the formation of acrylamide in the high-heat processed food is controlled radically, and the production process, the appearance, the flavor and the nutrition of the product are not changed.
The use of L-asparaginase to remove asparagine from the starting material is currently the most effective method for controlling the acrylamide level in high-heat processed foods. By adding asparaginase prior to baking or frying the food, the L-asparagine in the food material is hydrolyzed to L-aspartic acid and ammonia such that the L-asparagine cannot continue to participate in the Maillard reaction, thereby significantly reducing the amount of acrylamide that is produced during the thermal processing of the food.
The L-asparaginase has wide sources, and microorganisms such as plants, animals, bacteria, fungi, yeasts, actinomycetes and the like can produce the asparaginase, and the asparaginase from different sources has different biological characteristics. The extraction process of the L-asparaginase from animal and plant sources is complex, and the yield is low, so that the L-asparaginase from microorganism sources which is easy to culture and purify has great advantages, but the yield of the L-asparaginase from a wild strain is low, and the separation and purification method is complicated.
Disclosure of Invention
The invention aims to clone a gene fragment capable of coding L-asparaginase from genome DNA of Acinetobacter Y-3 by using a genetic engineering technology means, realize the efficient expression of the gene fragment in prokaryotic cells, and apply the gene fragment to fried foods, effectively inhibit the generation of acrylamide in the fried foods and radically control the generation of potential carcinogen acrylamide in the high-temperature processing of starch-containing foods.
The invention clones the L-asparaginase gene by a genetic engineering technology, constructs genetic engineering bacteria, obtains a novel recombinant L-asparaginase, realizes the efficient expression of the L-asparaginase gene, effectively controls the generation of potential cancerogenic substance acrylamide in the high-temperature processing of starch-containing foods, and has great application prospect in the field of food processing.
The invention separates an acinetobacter Y-3 from soil beside Yongxing town hot spring in Haikou city of Hainan province, and the classification is named acinetobacterAcinetobacter soli) The strain has been deposited in China general microbiological culture Collection center, with the address: the collection number of the strain is CGMCC NO 14831 in the national institute of microbiology, national institute of sciences, no.1, no. 3, beijing, chaoyang district, north Chen, west road.
An L-asparaginase gene AsAase derived from Acinetobacter as described aboveAcinetobacter soli) Y-3 has a nucleotide sequence shown in SEQ ID NO. 1.
The L-asparaginase gene AsAase encodes an L-asparaginase.
A method for preparing L-asparaginase, comprising the steps of:
(1) Performing PCR amplification of the L-asparaginase gene AsAase described above;
(2) Constructing an L-asparaginase gene AsAase prokaryotic expression vector;
(3) Recombinant L-asparaginase is expressed in prokaryotic cells.
In the preparation method of the L-asparaginase, the following primers are adopted for PCR amplification in the step (1):
F1-SacI:CGAGCTCATGAATAAAATTGCCTTAATTT;
R1-XhoI:CCGCTCGAGTTAATCCTCAGCCTTAATGGTGG;
F2-BglII:TGCAAAAGCCGCAGCAGATCTATGAATAAAATTGCCTT;
R2-KpnI:GAATTCGAGCTCCCGGGTACCTTAATCCTCAGCCTTA。
the preparation method of the L-asparaginase comprises the step (1)The PCR amplification system is as follows: 2 XTaq Master Mix 25. Mu.L, DNA template 2. Mu.L, dd H 2 O19. Mu.L, 2. Mu.L each of the upstream and downstream primers; PCR amplification conditions: pre-denaturation at 94℃for 3 min; denaturation at 94℃for 50s, annealing at 50℃for 50s, elongation at 72℃for 60s,30 cycles; extending at 72℃for 10min.
In the preparation method of the L-asparaginase, the expression vector used in the step (2) is any one of pET-30a, pET-32a, PCBS221 or PCBS 345.
In the preparation method of the L-asparaginase, the prokaryotic expression host used in the step (3) is escherichia coli or bacillus subtilis.
The application of the L-asparaginase in inhibiting the production of acrylamide in foods.
In the application, the raw materials are soaked in an L-asparaginase solution with the concentration of 20-30IU/mL, the material ratio is 1:2-1:3, the soaking temperature is 35-40 ℃, the time is 0.5-1.5h, and the acrylamide content can be reduced by 40-60%.
1. The invention digs Acinetobacter @Acinetobacter soli) The L-asparaginase gene derived from Y-3 and the expression thereof in prokaryotic cells are realized, and a novel genetic engineering strain for high-yield L-asparaginase is constructed.
2. The recombinant L-asparaginase AsAase is applied to fried foods, and the generation of acrylamide in the fried foods is effectively inhibited after the L-asparaginase is treated.
Drawings
FIG. 1 shows agarose gel electrophoresis patterns of an Acinetobacter Y-3L-asparaginase gene fragment
M, DNAMmarker: DS2000;1: acinetobacter Y-3L-asparaginase gene fragment AsAase
FIG. 2 is a schematic diagram showing electrophoresis of purified protein expressed by recombinant L-asparaginase
M: protein marker 26610;1: acinetobacter Y-3L-asparaginase purified protein
FIG. 3 is an acrylamide solution quality test chart of potato chips before and after treatment with L-asparaginase
A: diluting acrylamide extract of potato chips which are not subjected to enzyme treatment, and detecting a map of the liquid; b: enzyme-treated potato chips fried acrylamide extract liquid quality detection map
Detailed Description
Example 1
Acinetobacter @Acinetobacter soli) Cloning of Y-3L-asparaginase Gene
(1) Acinetobacter @Acinetobacter soli) Y-3 whole genome extraction: acinetobacter Y-3 thalli are collected by centrifugation, and the whole genome of the bacteria is extracted by adopting a Bacterial DNA kit kit of OMGA company.
(2) L-asparaginase primer design: according to NCBI databaseAcinetobacter soliThe AsAase gene sequence in the whole genome nucleic acid sequence is designed, and PCR upstream and downstream primers F1, R1, F2 and R2 of the L-asparaginase gene are designed:
F1:5’ CGAGCTCATGAATAAAATTGCCTTAATTT 3’(SacI)
R1:5’ CCGCTCGAGTTAATCCTCAGCCTTAATGGTGG 3’(XhoI)
F2:5’TGCAAAAGCCGCAGCAGATCTATGAATAAAATTGCCTT 3’(BglII)
R2:5’ GAATTCGAGCTCCCGGGTACCTTAATCCTCAGCCTTA 3’(KpnI)
(3) Cloning of the L-asparaginase gene: the whole genome of the acinetobacter Y-3 is used as a template, the primers designed above are used for PCR amplification, and a PCR amplification system is adopted: 2 XTaq Master Mix 25. Mu.L, DNA template 2. Mu.L, dd H 2 O19. Mu.L, 2. Mu.L each of the upstream and downstream primers; PCR amplification conditions: pre-denaturation at 94℃for 3 min; denaturation at 94℃for 50s, annealing at 50℃for 50s, elongation at 72℃for 60s,30 cycles; extending at 72℃for 10min. Gel recovery and purification are carried out by adopting a gel recovery kit, the purified product is connected with a pMD19-T carrier at 16 ℃ overnight, and the purified product is transformed into competent cells by a heat shock methodE.coliDH 5. Alpha. Was plated on ampicillin (Amp) resistant plates, positive transformants were picked up for sterilization (as shown in FIG. 1) and sent to the golden St. Nanj company for sequencing.
The sequencing result is analyzed by computer software to obtain a 981bp fragment (shown as SEQ ID NO. 1), namely the Acinetobacter L-asparaginase gene AsAase, which codes for a protein consisting of 326 amino acids.
Example 2
Expression and purification of recombinant L-asparaginase in E.coli
(1) Construction of an expression vector: the pMD19-T-AsAase and vector pET30a (+) were usedSac I andXhoi, double enzyme digestion is carried out at 37 ℃ for 9h. Recovery of target fragment, T, using gel recovery kit 4 The enzyme was ligated overnight at 16℃and transformed into competent cellsE.coliDH 5. Alpha. Was plated on kanamycin (Kana) resistant plates, positive transformants were picked up for enrichment, and the extracted plasmid was designated pET30a (+) -AsAase. Transformation of plasmid pET30a (+) -AsAase into competent cellsE.coliBL21 (DE 3), plated on Kana resistant plates, positive transformants were picked and sequenced.
(2) Expression of recombinant L-asparaginase: the recombinant bacteria were inoculated into LB liquid medium containing 100. Mu.g/mL Kana, cultured overnight at 37℃and 180rpm, and seed liquid was prepared. Then, the strain was transferred to 100ml of LB liquid medium containing the corresponding antibiotic at an inoculum size of 1%, between 37℃and OD 0.6-0.8, 100. Mu.l of IPTG (100 mg/ml) was added, and expression was induced overnight at 20 ℃.
(3) Purification of recombinant L-asparaginase: and (3) centrifugally collecting thalli at a low temperature, suspending thalli in a buffer solution, performing ultrasonic crushing, and centrifugally taking the supernatant again to obtain a crude enzyme solution. Since the target protein is fused with a histidine tag during plasmid construction, ni can be used 2+ -NTA affinity column purification of recombinant L-asparaginase. The method comprises the following steps:
loading: the final concentration of the sample is adjusted to 5mM imidazole to enhance adsorptivity, and the sample is subjected to membrane filtration treatment; ni before loading 2+ The NTA affinity column was equilibrated with 10 column volumes of 5mM imidazole buffer; sample is circularly loaded and adsorbed for 3 times; eluting the unadsorbed hetero protein with 5mM imidazole buffer solution after loading, and eluting the hetero protein with 50mM imidazole buffer solution;
eluting: eluting the hetero protein, eluting with 10 times of medium volume of 200mM imidazole buffer solution, collecting effluent liquid to obtain purified sample, and dialyzing to remove imidazole to obtain purified protein. Purified proteins were subjected to SDS-PAGE electrophoresis (as shown in FIG. 2).
Example 3
Expression and purification of recombinant L-asparaginase in bacillus subtilis
(1) Construction of an expression vector: the pMD19-T-AsAase and the vector PCBS345 were usedBglII and IIKpnI, double enzyme digestion is carried out at 37 ℃ for 9h. Recovery of target fragment, T, using gel recovery kit 4 The enzyme was ligated overnight at 16℃and transformed into competent cellsE.coliDH5 alpha is coated on a resistance plate, positive transformant is picked up for enrichment, and the extracted plasmid is named PCBS345-AsAase. Transformation of plasmid PCBS345-AsAase into competent cellsB. subtilis 001, picking positive transformants for sequencing.
(2) Expression of recombinant L-asparaginase: the recombinant bacteria are inoculated in a fermentation culture medium and cultured for 24-48h at 37 ℃ and 180 rpm.
(3) Purification of recombinant L-asparaginase: and (5) centrifugally collecting thalli at a low temperature, wherein the supernatant is crude enzyme liquid. The crude enzyme solution purification method is as follows:
ammonium sulfate fractional precipitation: adding ground (NH) to the supernatant at low temperature 4 ) 2 SO 4 Standing the powder at 0deg.C until the powder has different saturation, centrifuging to collect supernatant, and precipitating with (NH) 4 ) 2 SO 4 Is dissolved in Tris-HCl buffer.
Hydrophobic chromatography: and (3) after the redissolved precipitate passes through a membrane, loading the precipitate to a hydrophobic chromatography column, and collecting target proteins by gradient elution and removing salt ions by dialysis.
Example 4: application of L-asparaginase in food
The use of L-asparaginase in food has been supported by many prior art examples, which use potato chips as an example for application tests, as follows:
1. test procedure
(1) Potato chip manufacturing: cleaning potato, peeling, cutting into 2mm slices, and washing with ultrapure water to clean starch granules adsorbed on the surface of potato. Soaking potato chips in 20-30IU/mL pure enzyme solution at 35-40deg.C for 0.5-1 hr. Drying in an oven, frying, and cooling to room temperature.
(2) Separation and purification of acrylamide in a sample: 2g of the crushed sample is mixed with 10mL of deionized water, vortexed, subjected to ultrasonic treatment for 30min, centrifuged at 8000rpm for 10min, the supernatant is added with n-hexane in a ratio of 1:1 for degreasing, centrifuged at 8000rpm for 10min, and the aqueous phase is degreased once again. 5mL of methanol and 5mL of water are used for activating an ACA solid phase extraction column, a water phase is sampled, 5mL of water is used for leaching, a small column is dried by pumping, 5mL of methanol is used for eluting, nitrogen is blown to dryness, 0.5mL of ultrapure water is used for redissolving, and the acrylamide content of the liquid is measured after passing through a 0.22 mu m filter membrane.
2. Effect of L-asparaginase in inhibiting acrylamide formation in potato chips
The concentration of acrylamide extracted from potato chips after L-asparaginase treatment is reduced by 40-60% (as shown in FIG. 3) compared to that before treatment, which is effective in inhibiting the production of acrylamide in fried foods.
Sequence listing
<110> Nanjing agricultural university
<120> an Acinetobacter Y-3L-asparaginase gene, expression and use thereof
<140> 201811384145 .0
<141> 2018-11-20
<160> 5
<170> SIPOSequenceListing 1.0
<210> 1
<211> 980
<212> DNA
<213> acinetobacter soli
<400> 1
atgaataaaa ttgccttaat ttgtatgggt ggaacctttg gttgtattgg tgaaccgctt 60
gcaccaatgc cctatgatgc ctttcaaccc caattagaac gcattcttcc accacaatac 120
gcagtcgatt gttttaaagc cccttcaatt aaagatagta gcgcctgcac cgccgcagac 180
tggttgttac tggtacaaca gattaagggg ttgcagcttg agggctatac acactttgtg 240
gtgattcacg gtaccgatac catgagttat gcgtctgcaa ctttggcacg ctttttggga 300
caaacctgtc acgtggtgat cacgggtagt cagtatccgc tgcttaacac tgcgggcgac 360
gatacacgtg agtttaccga tgcgaacgag aatttatact ttgcattaga gagcgttcaa 420
cgtttagcaa gcggtaccta tcaggctttt catcatcaaa tttttcacgg tcaaaccgtt 480
cttaaaaccc atacaactga gctggatgca ttttccggtg tctcggccga tgcaccttgt 540
gatacggtca caaatgcgat ggctgtagat gctgccatgg ttgcacgtgc cgatgaactg 600
gccatagtga atctgatgca tcaacctgtg cgtccagcgc acttggcaca gcaacttgaa 660
aatattgcac agcgaccacc gcacttttta attttacaag gattcggaac cggtaatatt 720
gcggtcaatg acgccattct ggcgcagttt caacaattac gagcccaagg ctgtctggtg 780
gtgttaacta cacaagtcac cttcggcaaa attgatcagc gctatgccat tagtgactgg 840
gtacattgtg caggcattgc caccaatacc acgcatggtc atgccgatct gtatgccaag 900
ctgctacaac tttacttaga gtatgatgat gctgaaggtt ggtatcgaca ctgggatacc 960
accattaagg ctgaggatta 980
<210> 2
<211> 29
<212> DNA
<213> Artificial Sequence
<400> 2
cgagctcatg aataaaattg ccttaattt 29
<210> 3
<211> 32
<212> DNA
<213> Artificial Sequence
<400> 3
ccgctcgagt taatcctcag ccttaatggt gg 32
<210> 4
<211> 38
<212> DNA
<213> Artificial Sequence
<400> 4
tgcaaaagcc gcagcagatc tatgaataaa attgcctt 38
<210> 5
<211> 37
<212> DNA
<213> Artificial Sequence
<400> 5
gaattcgagc tcccgggtac cttaatcctc agcctta 37
Claims (10)
1. Acinetobacter from soilAcinetobacter soli) Y-3 is preserved in China general microbiological culture Collection center (CGMCC) with the preservation number of CGMCC NO:14831.
2. An L-asparaginase gene AsAase derived from Acinetobacter as set forth in claim 1Acinetobacter soli) Y-3 has a nucleotide sequence shown in SEQ ID NO. 1.
3. The L-asparaginase encoded by the L-asparaginase gene AsAase of claim 2.
4. A method for preparing L-asparaginase, comprising the steps of:
(1) Performing PCR amplification of the L-asparaginase gene AsAase of claim 2;
(2) Constructing an L-asparaginase gene AsAase prokaryotic expression vector;
(3) Recombinant L-asparaginase is expressed in prokaryotic cells.
5. The method of claim 4, wherein the PCR amplification in step (1) uses the following primers:
F1-SacI:CGAGCTCATGAATAAAATTGCCTTAATTT;
R1- XhoI:CCGCTCGAGTTAATCCTCAGCCTTAATGGTGG;
F2- BglII:TGCAAAAGCCGCAGCAGATCTATGAATAAAATTGCCTT;
R2- KpnI:GAATTCGAGCTCCCGGGTACCTTAATCCTCAGCCTTA。
6. the method of claim 4, wherein the PCR amplification system in step (1) is: 2 XTaq Master Mix 25. Mu.L, DNA template 2. Mu.L, dd H 2 O19. Mu.L, 2. Mu.L each of the upstream and downstream primers; PCR amplification conditions: pre-denaturation at 94℃for 3 min; denaturation at 94℃for 50s, annealing at 50℃for 50s, elongation at 72℃for 60s,30 cycles; extending at 72℃for 10min.
7. The method according to claim 4, wherein the expression vector used in the step (2) is any one of pET-30a, pET-32a, PCBS221 or PCBS 345.
8. The method according to claim 4, wherein the prokaryotic cell used in the step (3) is Escherichia coli or Bacillus subtilis.
9. Use of the L-asparaginase according to claim 3 in the inhibition of acrylamide formation in food products.
10. The use according to claim 9, wherein the raw material is soaked in an L-asparaginase solution having a concentration of 20-30IU/mL, the material to L-asparaginase solution ratio is 1:2-1:3, the soaking temperature is 35-40 ℃, and the time is 0.5-1.5h.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711228833.3A CN108728371A (en) | 2017-11-29 | 2017-11-29 | The expression and application of a kind of acinetobacter calcoaceticus Y-3 and its altheine enzyme gene |
CN2017112288333 | 2017-11-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109337845A CN109337845A (en) | 2019-02-15 |
CN109337845B true CN109337845B (en) | 2023-11-07 |
Family
ID=63940326
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711228833.3A Withdrawn CN108728371A (en) | 2017-11-29 | 2017-11-29 | The expression and application of a kind of acinetobacter calcoaceticus Y-3 and its altheine enzyme gene |
CN201811384145.0A Active CN109337845B (en) | 2017-11-29 | 2018-11-20 | Acinetobacter Y-3L-asparaginase gene and expression and application thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711228833.3A Withdrawn CN108728371A (en) | 2017-11-29 | 2017-11-29 | The expression and application of a kind of acinetobacter calcoaceticus Y-3 and its altheine enzyme gene |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN108728371A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110256535B (en) * | 2019-06-14 | 2021-01-01 | 中国石油大学(华东) | L-asparaginase XiDL and coding gene and application thereof |
CN112725318A (en) * | 2020-12-31 | 2021-04-30 | 南京农业大学 | Preparation method and application of mycobacterium gordonii L-asparaginase |
-
2017
- 2017-11-29 CN CN201711228833.3A patent/CN108728371A/en not_active Withdrawn
-
2018
- 2018-11-20 CN CN201811384145.0A patent/CN109337845B/en active Active
Non-Patent Citations (2)
Title |
---|
asparaginase [Acinetobacter soli];NCBI Reference Sequence: WP_025095353.1;《GenBank》;20170816;第1页 * |
陈辉.降低丙烯酰胺危害的措施.《食品安全概论》.中国轻工业出版社,2011,(第1版),第129-130页. * |
Also Published As
Publication number | Publication date |
---|---|
CN109337845A (en) | 2019-02-15 |
CN108728371A (en) | 2018-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7695751B2 (en) | Detoxifizyme with activity of transforming aflatoxin and the gene encodes thereof | |
CN110527674A (en) | Polypeptide, its polynucleotides of separation, and the additive comprising polypeptide, its purposes and method | |
CN112961846B (en) | Zearalenone degrading enzyme mutant with improved enzyme activity and coding gene and application thereof | |
CN110669745B (en) | Zearalenone degrading enzyme mutant with improved thermal stability and application thereof | |
CN109337845B (en) | Acinetobacter Y-3L-asparaginase gene and expression and application thereof | |
CN112760299B (en) | Glucose oxidase mutant with improved thermal stability as well as coding gene and application thereof | |
CN107760621A (en) | Iprodione degradation bacteria, digestive enzyme IpaH and its encoding gene ipaH and its application | |
CN111394326B (en) | Vomitoxin degrading enzyme DDH and application thereof in detoxification of trichothecene toxins | |
JP4663631B2 (en) | AMP deaminase derived from actinomycetes and use thereof | |
CN104212757A (en) | Method for high-efficiently producing L-theanine through production of coli [gamma]-glutamylmethylamine synthetase with escherichia coli | |
CN117264975A (en) | Cloning, expression and application of vomitoxin detoxification enzyme gene | |
CN109097316B (en) | Method for improving yield of antifungal peptide bacillus D by over-expressing degU gene | |
CN109022474B (en) | Method for improving yield of antifungal peptide bacillus D by over-expressing spo0A gene | |
CN107022536B (en) | Cellulase mutant with high catalytic efficiency, and gene and application thereof | |
CN108410843B (en) | New pullulanase, and coding gene and application thereof | |
CN108102934B (en) | Aspergillus niger strain capable of producing pectin lyase at high yield | |
CN109593661B (en) | Gene engineering bacterium for producing echinocandin B and construction method and application thereof | |
CN113355334B (en) | Corn salt-tolerant gene and application thereof | |
CN113174352B (en) | Bacillus subtilis HF1 mutant and construction method and application thereof | |
CN110117583A (en) | Thermostabilization and the ratio phytase ECAPPA mutant living improved and its gene and application | |
CN114958804A (en) | Neutral phytase mutant | |
CN111549007B (en) | Transaminase TSTA, preparation method and application | |
Tork et al. | New tannase-producing Lactobacillus Sp. Nrc10: Gene cloning, enzyme purification, and characterization | |
CN107058267B (en) | Modified lignocellulose and application thereof | |
CN112410319B (en) | Nuclease At _ NrnCM and coding gene and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |